Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: August 28, 2026Value: $127mmStatus: PendingCenterview as exclusive financial advisor to Algonquin on its sale of its 64% stake in Suralis S.A. to a fund managed by Toesca S.A. Administradora General de Fondos
Announced: August 12, 2026Status: PendingCenterview as exclusive financial advisor to Bentley Systems on their divestiture of its IBM Maximo consulting, implementation and hosting business, Cohesive Solutions to Naviam
Announced: August 10, 2026Value: Up to $1.32bnStatus: PendingCenterview as financial advisor to Actio Biosciences on their sale to Jazz
Announced: July 31, 2026Value: $2.2bnStatus: PendingCenterview as financial advisor to Santander on their exchange offer to acquire the outstanding shares of Santander Brazil
Announced: July 29, 2026Value: $350mmStatus: PendingCenterview as exclusive financial advisor to MiMedx on their acquisition of Sanara Medtech.
Announced: July 22, 2026Value: $1.5bnStatus: PendingCenterview as exclusive financial advisor to BioLife Solutions on their sale to Repligen
Announced: July 20, 2026Value: $1.9bnStatus: PendingCenterview as lead advisor to Personalis on their sale to Tempus AI
Status: PendingCenterview Partners as exclusive financial advisor to Batibig's co-founders, management and shareholders on their exclusive negotiations with Charterhouse Capital Partners.
Announced: July 16, 2026Value: $3.9bnStatus: PendingCenterview as Financial Advisor to AtaiBeckley on its sale to Eli Lilly
Announced: July 14, 2026Value: $500mmStatus: PendingCenterview as Exclusive Financial Advisor to Thomson Reuters on its sale of a 51% equity stake in its Global Prints business to KKR.
Announced: July 13, 2026Status: PendingCenterview as Lead Financial Advisor to PANTHERx Rare on its sale to Warburg Pincus-Led Investor Group.
Announced: July 1, 2026Value: $800mmStatus: PendingCenterview as exclusive financial advisor to Memo Therepeutics on their sale to Ipsen
Announced: June 30, 2026Value: $3.1bnStatus: PendingCenterview as exclusive financial advisor to Schneider Electric on their acquisition of Cognite
Announced: June 9, 2026Value: $10.6bnStatus: PendingCenterview partners as exclusive financial advisor to Nuvalent
Announced: June 8, 2026Value: $460mmStatus: PendingCenterview as Financial Advisor to Standard BioTools on Merger with Treeline Biosciences